Nerve Decompression and Restless Legs Syndrome: A Retrospective Analysis

Introduction Restless legs syndrome (RLS) is a prevalent sleep disorder affecting quality of life and is often comorbid with other neurological diseases, including peripheral neuropathy. The mechanisms related to RLS symptoms remain unclear, and treatment options are often aimed at symptom relief rather than etiology. RLS may present in distinct phenotypes often described as “primary” vs. “secondary” RLS. Secondary RLS is often associated with peripheral neuropathy. Nerve decompression surgery of the common and superficial fibular nerves is used to treat peripheral neuropathy. Anecdotally, surgeons sometimes report improved RLS symptoms following nerve decompression for peripheral neuropathy. The purpose of this retrospective analysis was to quantify the change in symptoms commonly associated with RLS using visual analog scales (VAS). Methods Forty-two patients completed VAS scales (0–10) for pain, burning, numbness, tingling, weakness, balance, tightness, aching, pulling, cramping, twitchy/jumpy, uneasy, creepy/crawly, and throbbing, both before and 15 weeks after surgical decompression. Results Subjects reported significant improvement among all VAS categories, except for “pulling” (P = 0.14). The change in VAS following surgery was negatively correlated with the pre-surgery VAS for both the summed VAS (r = −0.58, P < 0.001) and the individual VAS scores (all P < 0.01), such that patients who reported the worst symptoms before surgery exhibited relatively greater reductions in symptoms after surgery. Conclusion This is the first study to suggest improvement in RLS symptoms following surgical decompression of the common and superficial fibular nerves. Further investigation is needed to quantify improvement using RLS-specific metrics and sleep quality assessments.

[1]  J. Connor,et al.  Iron and restless legs syndrome: treatment, genetics and pathophysiology. , 2017, Sleep medicine.

[2]  K. Chaudhuri,et al.  Practice guideline summary: Treatment of restless legs syndrome in adults , 2016, Neurology.

[3]  Ravi Gupta,et al.  A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis–Ekbom disease) , 2016, Annals of Indian Academy of Neurology.

[4]  A. Walters,et al.  Validation of the Kohnen Restless Legs Syndrome-Quality of Life instrument. , 2016, Sleep medicine.

[5]  W. Oertel,et al.  Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. , 2016, Sleep medicine.

[6]  James C. Anderson Common Fibular Nerve Compression: Anatomy, Symptoms, Clinical Evaluation, and Surgical Decompression. , 2016, Clinics in podiatric medicine and surgery.

[7]  N. Cuellar,et al.  Peripheral diabetic neuropathy or restless legs syndrome in persons with type 2 diabetes mellitus: Differentiating diagnosis in practice , 2015, Journal of the American Association of Nurse Practitioners.

[8]  L. Webster Opioid-Induced Constipation. , 2015, Pain medicine.

[9]  S. Bhoi,et al.  Neuropathy in a cohort of restless leg syndrome patients , 2015, Journal of Clinical Neuroscience.

[10]  S. Hollingworth,et al.  Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia , 2015, Drugs - Real World Outcomes.

[11]  M. Kon,et al.  The effect of lower extremity nerve decompression on health‐related quality of life and perception of pain in patients with painful diabetic polyneuropathy: a prospective randomized trial , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[12]  L. Wilkins MRI measurement of brain iron in patients with restless legs syndrome , 2015, Neurology.

[13]  Richard P Allen,et al.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. , 2014, Sleep medicine.

[14]  E. Kocabicak,et al.  Restless Leg Syndrome and Sleep Quality in Lumbar Radiculopathy Patients , 2014, Behavioural neurology.

[15]  Yongmin Chang,et al.  Altered white matter integrity in primary restless legs syndrome patients: diffusion tensor imaging study , 2014, Neurological research.

[16]  R. P. Allen,et al.  Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome , 2014 .

[17]  M. Zobeiri,et al.  Restless Leg Syndrome in Diabetics Compared with Normal Controls , 2014, Sleep disorders.

[18]  A. Kume Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose? , 2014, Neuropsychiatric disease and treatment.

[19]  J. Winkelmann,et al.  Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension , 2013, The Lancet Neurology.

[20]  Jun Shi,et al.  Evaluation of the clinical efficacy of multiple lower-extremity nerve decompression in diabetic peripheral neuropathy , 2013, British journal of neurosurgery.

[21]  A. Rader,et al.  Low long-term risk of foot ulcer recurrence after nerve decompression in a diabetes neuropathy cohort. , 2013, Journal of the American Podiatric Medical Association.

[22]  M. Narita,et al.  Differential activation of the μ‐opioid receptor by oxycodone and morphine in pain‐related brain regions in a bone cancer pain model , 2013, British journal of pharmacology.

[23]  Ravi Gupta,et al.  Restless Legs Syndrome: a common disorder, but rarely diagnosed and barely treated--an Indian experience. , 2012, Sleep medicine.

[24]  A. Dellon,et al.  A Positive Tinel Sign as Predictor of Pain Relief or Sensory Recovery after Decompression of Chronic Tibial Nerve Compression in Patients with Diabetic Neuropathy , 2012, Journal of Reconstructive Microsurgery.

[25]  L. Ferini-Strambi,et al.  Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis‐Ekbom Disease): Results from a prospective, multicenter study over 66 weeks , 2012, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. Connor,et al.  Profile of altered brain iron acquisition in restless legs syndrome. , 2011, Brain : a journal of neurology.

[27]  J. Kalita,et al.  Treatment of restless legs syndrome with pregabalin: A double-blind, placebo-controlled study , 2011, Neurology.

[28]  J. Tolson,et al.  A 52-Week Study of Gabapentin Enacarbil in Restless Legs Syndrome , 2011, Clinical neuropharmacology.

[29]  Xiang Gao,et al.  Restless legs syndrome and Parkinson's disease in men , 2010, Movement disorders : official journal of the Movement Disorder Society.

[30]  Y. Rajabally,et al.  Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy , 2010, Muscle & nerve.

[31]  G. Gigli,et al.  Effects of Restless Legs Syndrome on Quality of Life and Psychological Status in Patients With Type 2 Diabetes , 2010, The Diabetes educator.

[32]  Barry T. Peterson,et al.  A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. , 2009, Sleep medicine.

[33]  S. Evers,et al.  Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey , 2009, Journal of Neurology.

[34]  A. Walters,et al.  Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial , 2009, Clinical neuropharmacology.

[35]  E. Lainey,et al.  Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. , 2009, Journal of neurology, neurosurgery, and psychiatry.

[36]  Ekbom Ka Restless legs; a report of 70 new cases. , 2009 .

[37]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[38]  R. Postuma,et al.  Is there a higher risk of restless legs syndrome in peripheral neuropathy? , 2009, Neurology.

[39]  R. Allen,et al.  Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset. , 2008, Sleep medicine.

[40]  K. Chaudhuri,et al.  Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. , 2008, Sleep medicine.

[41]  W. Oertel,et al.  Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet Neurology.

[42]  G. Comi,et al.  Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage , 2008, Multiple sclerosis.

[43]  G. Gigli,et al.  Association of restless legs syndrome in type 2 diabetes: a case-control study. , 2007, Sleep.

[44]  J. Lefaucheur,et al.  Restless legs syndrome is frequently overlooked in patients being evaluated for polyneuropathies , 2007, European journal of neurology.

[45]  F. Gemignani,et al.  Restless legs syndrome associated with peripheral neuropathy , 2007, European journal of neurology.

[46]  S. Calzetti,et al.  Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy , 2007, Journal of the peripheral nervous system : JPNS.

[47]  G. Plazzi,et al.  Augmentation of restless legs syndrome with long‐term tramadol treatment , 2007, Movement disorders : official journal of the Movement Disorder Society.

[48]  A. Bentley,et al.  Can the Sensory Symptoms of Restless Legs Syndrome Be Assessed Using a Qualitative Pain Questionnaire? , 2007, The Clinical journal of pain.

[49]  C. Halldin,et al.  Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. , 2006, Brain : a journal of neurology.

[50]  M. Partinen,et al.  Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study. , 2006, Sleep medicine.

[51]  W. Ondo,et al.  Association between restless legs syndrome and essential tremor , 2006, Movement disorders : official journal of the Movement Disorder Society.

[52]  A. Dolphin,et al.  A short history of voltage‐gated calcium channels , 2006, British journal of pharmacology.

[53]  G. Deuschl,et al.  Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. , 2005, Journal of neurology.

[54]  Damien Dauphinee,et al.  Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompression. , 2005, Journal of the American Podiatric Medical Association.

[55]  Richard P Allen,et al.  Restless legs syndrome prevalence and impact: REST general population study. , 2005, Archives of internal medicine.

[56]  Y. Lo,et al.  Restless hand symptoms in carpal tunnel syndrome , 2004, International journal of clinical practice.

[57]  W. Paulus,et al.  Why do restless legs occur at rest?—pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2) , 2004, Clinical Neurophysiology.

[58]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[59]  J. Connor,et al.  Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome , 2004, Journal of the Neurological Sciences.

[60]  Richard P Allen,et al.  Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. , 2004, Sleep medicine.

[61]  L. Ferini-Strambi,et al.  Epidemiology and clinical findings of restless legs syndrome. , 2004, Sleep medicine.

[62]  Richard P Allen,et al.  An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. , 2004, Sleep.

[63]  R. Vetrugno,et al.  Restless legs syndrome: an historical note. , 2004, Sleep medicine.

[64]  J. Beard Iron deficiency alters brain development and functioning. , 2003, The Journal of nutrition.

[65]  Richard P Allen,et al.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.

[66]  角田 明良,et al.  結腸癌術後の早期離床・早期経口摂取に関するProspective Randomized Trial , 2002 .

[67]  A. Walters,et al.  Long‐Term follow‐up on restless legs syndrome patients treated with opioids , 2001, Movement disorders : official journal of the Movement Disorder Society.

[68]  M. Kryger,et al.  Sleep complaints and restless legs syndrome in adult type 2 diabetics. , 2001, Sleep medicine.

[69]  J. Beard,et al.  Iron deficiency decreases dopamine D1 and D2 receptors in rat brain , 2001, Pharmacology Biochemistry and Behavior.

[70]  C. Bassetti,et al.  Restless Legs Syndrome: A Clinical Study of 55 Patients , 2001, European Neurology.

[71]  J. McArthur,et al.  Subclinical sensory neuropathy in late-onset restless legs syndrome , 2000, Neurology.

[72]  J. Heffner,et al.  Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen. , 2000, Sleep.

[73]  M. Kryger,et al.  Restless legs syndrome in 218 patients: associated disorders. , 2000, Sleep medicine.

[74]  A. Vinik Diabetic neuropathy: pathogenesis and therapy. , 1999, The American journal of medicine.

[75]  J. Matheson,et al.  Restless legs syndrome in patients with polyneuropathy , 1996, Muscle & nerve.

[76]  J. O’Hare,et al.  Prevalence and forms of neuropathic morbidity in 800 diabetics , 1994, Irish journal of medical science.

[77]  F. Lewis The role of the saphenous nerve in insomnia: a proposed etiology of restless legs syndrome. , 1991, Medical hypotheses.

[78]  D. Ilstrup,et al.  A Double-blind, Placebo-Controlled Study , 2017 .

[79]  James C. Anderson Anatomy, Symptoms, Clinical Evaluation, and Surgical Decompression , 2016 .

[80]  B. Liu,et al.  Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study. , 2015, Sleep medicine.

[81]  M. Contini,et al.  Painful polyneuropathy associated with restless legs syndrome. Clinical features and sensory profile. , 2013, Sleep medicine.

[82]  W. Kremers,et al.  Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. , 2008, Current medical research and opinion.

[83]  R. Domínguez,et al.  [Restless legs syndrome in Fabry disease: clinical feature associated to neuropathic pain is overlooked]. , 2007, Revista de neurologia.

[84]  R. Michael Alvarez,et al.  Web-Based Survey , 2005 .

[85]  Richard P Allen,et al.  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. , 2003, Sleep medicine.

[86]  J. Connor,et al.  Relationship of iron to oligodendrocytes and myelination. , 1996, Glia.

[87]  P C Bucy,et al.  Historical note , 1984, Surgical neurology.

[88]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[89]  T. Willis,et al.  The London practice of physick , 1973 .

[90]  H. P. Teglbjaerg Pathogenesis and therapy. , 1954, Acta psychiatrica et neurologica Scandinavica.

[91]  K. Ekbom Restless legs; a report of 70 new cases. , 1950, Acta medica Scandinavica. Supplementum.

[92]  G. A. Moore,et al.  randomised double blind placebo controlled trial , 2022 .